Finanzwire Finanzwire
Basculer en Français
10491 Companies
221179 Keywords
150421 Articles
116987 Press releases
Headlines Articles Press releases Nymox Pharmaceutical Corporation Remove
  1. Home
  2. Companies
  3. Nymox Pharmaceutical Corporation
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/02/2026 at 22:05, 1 hour 49 minutes ago

    Nymox Pharmaceutical Corporation Update on Nymozarfex Approval

    Clinical Data Financial Constraints Regulatory Submission BPH Treatment Nymozarfex Approval
  • PRESS RELEASE

    published on 06/02/2026 at 22:00, 1 hour 54 minutes ago

    NYMOX Provides Current Update

    Nymox Pharmaceutical focuses on re-submission of Nymozarfex for US marketing approval. Updates needed for EU approvals. Company confident in treatment efficacy
    Treatment Efficacy Nymox Pharmaceutical Nymozarfex US Marketing Approval EU Approvals
    Logo of Nymox Pharmaceutical Corporation
  • BRIEF

    published on 03/27/2026 at 21:05, 2 months 6 days ago

    Nymox Pharmaceutical Corporation Provides Recent Updates

    Board Changes CEO Stock Purchase Nymox Updates Prostate Treatments In Memoriam
  • PRESS RELEASE

    published on 03/27/2026 at 21:00, 2 months 6 days ago

    NYMOX Provides Recent Updates

    Nymox Pharmaceutical Corporation provides updates on Board changes and progress of prostate treatments, CEO purchases shares, and mourns Co-Chairman's passing
    Prostate Treatments Nymox Pharmaceutical Corporation Board Updates CEO Shares Purchase Co-Chairman Passing
    Logo of Nymox Pharmaceutical Corporation
Accesswire
  • Published on 06/02/2026 at 22:30, 1 hour 24 minutes ago

    INEO Announces Effective Date of Share Consolidation

  • Published on 06/02/2026 at 22:00, 1 hour 54 minutes ago

    NYMOX Provides Current Update

  • Published on 06/02/2026 at 19:45, 4 hours 9 minutes ago

    Announces Plans to Repurchase Common Shares

  • Published on 06/02/2026 at 19:40, 4 hours 14 minutes ago

    Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property

  • Published on 06/02/2026 at 16:15, 7 hours 39 minutes ago

    Vulcan Minerals Inc. - Drilling to Resume at Carbonear Zinc-Lead SEDEX project in Newfoundland

View all ACCESSWIRE
EQS Group
  • Published on 06/02/2026 at 22:35, 1 hour 19 minutes ago

    Hycroft Delivers $10 Billion NPV from Technical Report at Spot Prices While Advancing High-Grade Brimstone and Vortex Silver Discoveries

  • Published on 06/02/2026 at 19:50, 4 hours 4 minutes ago

    Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale

  • Published on 06/02/2026 at 19:41, 4 hours 13 minutes ago

    Avolta prices EUR 400 million of Senior Notes

  • Published on 06/02/2026 at 19:28, 4 hours 26 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 06/02/2026 at 18:24, 5 hours 30 minutes ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 06/02/2026 at 18:03, 5 hours 51 minutes ago

    Total number of voting rights and shares making up the share capital at May 31, 2026

  • Published on 06/02/2026 at 17:42, 6 hours 12 minutes ago

    Aéroports de Paris SA - Shares and voting rights as of 31 May 2026

  • Published on 06/02/2026 at 17:40, 6 hours 14 minutes ago

    Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million

  • Published on 06/02/2026 at 08:00, 15 hours 54 minutes ago

    EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET

  • Published on 06/02/2026 at 07:30, 16 hours 24 minutes ago

    OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy